Fabrice Bonnet

11PUBLICATIONS
18CO-AUTHORS
Epidemiological modellingCardiology (incl. cardiovascular diseases)Public health nutritionRural community developmentHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 14, 2026
Risk of hospitalization for adrenal insufficiency following long-term systemic and inhaled corticosteroid use: a comparative TriNetX network analysis.

Patricia Vaduva, Fabrice Bonnet, Grégoire Fauchier

|Sep 09, 2025
Testosterone therapy and the risk of atrial fibrillation, venous thromboembolism and cardiovascular events in cis men with hypogonadism and trans men.

Fabrice Bonnet, Patricia Vaduva, Beverley Balkau

|Jun 20, 2024
A review of the latest real-world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions?

Fabrice Bonnet, Mark E Cooper, Laetitia Kopp

|Feb 28, 2024
The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD-REIN cohort study.

Fabrice Bonnet, Beverley Balkau, Oriane Lambert

|Mar 12, 2023
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.

Brenda Bongaerts, Oliver Kuss, Fabrice Bonnet

|Jul 02, 2021
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.

Fabrice Bonnet, Hungta Chen, Andrew Cooper

Pageof 2

Frequent Collaborators

2 joint publications

Beverley Balkau

2 joint publications

Marίlia B Gomes

2 joint publications

Linong Ji

2 joint publications

Hirotaka Watada